[go: up one dir, main page]

ATE399474T1 - Use of unsaturated fatty acids for the reduction of appetite or food intake - Google Patents

Use of unsaturated fatty acids for the reduction of appetite or food intake

Info

Publication number
ATE399474T1
ATE399474T1 AT04005383T AT04005383T ATE399474T1 AT E399474 T1 ATE399474 T1 AT E399474T1 AT 04005383 T AT04005383 T AT 04005383T AT 04005383 T AT04005383 T AT 04005383T AT E399474 T1 ATE399474 T1 AT E399474T1
Authority
AT
Austria
Prior art keywords
fatty acids
food intake
appetite
reduction
unsaturated fatty
Prior art date
Application number
AT04005383T
Other languages
English (en)
Inventor
Doris Bell
Ralf Zink
Albrecht Weiss
Original Assignee
Cognis Ip Man Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34746026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE399474(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cognis Ip Man Gmbh filed Critical Cognis Ip Man Gmbh
Application granted granted Critical
Publication of ATE399474T1 publication Critical patent/ATE399474T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04005383T 2004-03-06 2004-03-06 Use of unsaturated fatty acids for the reduction of appetite or food intake ATE399474T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04005383A EP1570752B1 (de) 2004-03-06 2004-03-06 Use of unsaturated fatty acids for the reduction of appetite or food intake

Publications (1)

Publication Number Publication Date
ATE399474T1 true ATE399474T1 (de) 2008-07-15

Family

ID=34746026

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04005383T ATE399474T1 (de) 2004-03-06 2004-03-06 Use of unsaturated fatty acids for the reduction of appetite or food intake

Country Status (6)

Country Link
US (1) US20050222259A1 (de)
EP (1) EP1570752B1 (de)
JP (1) JP2005247853A (de)
AT (1) ATE399474T1 (de)
DE (1) DE602004014716D1 (de)
ES (1) ES2308056T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2626368T3 (pl) 2004-07-19 2017-06-30 Biocon Limited Koniugaty insulina-oligomer, ich formulacje i zastosowania
GB0514463D0 (en) * 2005-01-31 2005-08-17 Loders Croklaan Bv Use of pinolenic acid
DK2203181T3 (en) 2007-10-16 2018-05-28 Biocon Ltd An orally administrable solid composition and a method thereof
US8603023B2 (en) * 2010-05-26 2013-12-10 Ethicon Endo-Surgery, Inc. Intestinal brake inducing intraluminal therapeutic substance eluting devices and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554646A (en) * 1992-04-29 1996-09-10 Wisconsin Alumni Research Foundation Method for reducing body fat in animals
JPH11209279A (ja) * 1998-01-05 1999-08-03 Natural Ltd As 体重減少および肥満処置の方法
US6696584B2 (en) * 1998-05-04 2004-02-24 Natural Asa Isomer enriched conjugated linoleic acid compositions
DE10045059A1 (de) * 2000-09-12 2002-03-21 Basf Ag Therapeutische Kombination von Liponsäure und Konjuensäuren zur Behandlung diabetischer Störungen
EA006556B1 (ru) * 2001-03-27 2006-02-24 Те Риджентс Оф Те Юниверсити Оф Калифорния Способы, соединения и композиции для борьбы с ожирением и регулирования метаболизма жирных кислот

Also Published As

Publication number Publication date
US20050222259A1 (en) 2005-10-06
EP1570752B1 (de) 2008-07-02
DE602004014716D1 (de) 2008-08-14
EP1570752A1 (de) 2005-09-07
ES2308056T3 (es) 2008-12-01
JP2005247853A (ja) 2005-09-15

Similar Documents

Publication Publication Date Title
WO2006017627A3 (en) Dietary compositions comprising docosahexaenoic acid and eicosapentaenoic acid and use thereof for treating insulin resistance
BRPI0813320A2 (pt) Fração lipídica, e, produto farmacêutico ou nutricional
EA200801602A1 (ru) Эмульсия
GB2459809A (en) Fatty acid formulations and methods of use thereof
MXPA04009765A (es) Metodo para mejorar la absorcion de la vitamina e por una mascota animal.
WO2011097273A8 (en) Methods and compositions for treating non-alcoholic fatty liver disease with docosahexaenoic acid and n-acetyl l-cysteine
EA200801138A1 (ru) Применение флибансерина для лечения расстройств полового влечения в предклимактерический период
WO2010041017A3 (en) Chewable gelled emulsions
MX2009001156A (es) Composiciones de vitamina d y metodo de administracion a un ser humano.
WO2005046580A3 (en) Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism
CY1114251T1 (el) Χρηση ενος συνδυασμου ο οποιος περιλαμβανει l-kapnitinh ή αλκανοϋλ l-kapnitinh, λιποδιαλυτη βενζοκινονη και ωμεγα-3-πολυακορεστο λιπαρο οξυ για την παρασκευη ενος διαιτητικου συμπληρωματος ή φαρμακου για τη θεραπευτικη αγωγη παθησεων του κερατοειδους
BRPI0512528B8 (pt) uso de ácidos graxos poliinsaturados, composição nutricional, e, uso de uma composição
NO20084478L (no) Konjugerte lipidderivater
JP2007238598A5 (de)
WO2008102017A3 (en) Food comprising polyunsaturated fatty acids for the prevention of chronic diseases
GT200800235A (es) Formulacion de medicamento liquida
ATE399474T1 (de) Use of unsaturated fatty acids for the reduction of appetite or food intake
WO2006108692A3 (en) Dosage form for oral administration of a vitamin
TW200626134A (en) Treatment of IgA nephropathy with Omega-3 fatty acids
DOP2006000208A (es) Suplementos nutricionales con fitosterol
Wolff et al. Reassessment of the contribution of bovine milk fats to the trans-18: 1 isomeric acid consumption by European populations. Additional data for rumenic (cis-9, trans-11 18: 2) acid
ATE217494T1 (de) Orale darreichungsform
ATE452120T1 (de) Fettsäure-benzenediol-derivate sowie herstellungs-und verwendungsverfahren dafür
WO2006109194A3 (en) Chromium-fatty acid compounds and methods of making and using thereof
TW200735781A (en) Food product

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties